The reduced form of HMGB1 binds to the RAGE and induces Beclin-1-dependent autophagy, promoting tumor cell resistance to diverse chemotherapeutic agents including alkylators, tubulin disruptors, and DNA intercalators [96,97]. The gene discussed is HMGB1; the disease is neoplasm.